By Breakingviews Leveraged buyouts have become a drag. KKR, Carlyle, and others are enduring a slump in the wheeling and dealing of…
Innovex Downhole Solutions Starts IPO On Slowing Revenue Growth (Pending:INVX)
By Press Room
4 Mins read
Innovex Downhole In Brief Innovex Downhole Solutions, Inc. (INVX) has filed to raise $100 million in an IPO of its common stock,…
Investment Thesis Atkore (NYSE:ATKR) has delivered an exceptional return over the past five years, outperforming the S&P500 index by a substantial margin….
GSK plc (NYSE:GSK) 42nd Annual JP Morgan Healthcare Conference January 9, 2024 10:30 AM ET Company Participants Emma Walmsley – Chief Executive…
Written by Nick Ackerman. All it took was the expectations for rate cuts next year, and that sent the risk-free Treasury Rates…
I upgraded my thesis on The Coca-Cola Company (NYSE:KO) stock in mid-September 2023, assessing it was reasonable to be more constructive after…
Utilities stocks came under significant pressure for most of 2023, as the Fed interest rate hikes knocked much-needed sense into over-optimistic investors….
NBB: Yield Is Low Versus Alternatives And Bonds Are Overpriced (NYSE:NBB)
By Press Room
14 Mins read
The Nuveen Taxable Municipal Income Fund (NYSE:NBB) is a closed-end fund, or CEF, that investors can employ to generate a high level…
Thesis To kick off 2024 I decided to take a look at the energy markets from a different perspective. The market doesn’t…
Keros Therapeutics: Interesting Early Data From A Promising Molecule (Downgrade) (KROS)
By Press Room
3 Mins read
In April, I covered Keros Therapeutics, Inc. (NASDAQ:KROS), and found it interesting. Keros had three published datasets from three clinical-stage programs. The…